Pharmacological Phenotype Prediction Platform Using Multi-Omics Integration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current systems fail to accurately predict pharmacological phenotypes, including drug response and disease risk, as they do not utilize chromatin state, genomic regulatory elements, epigenomics, proteomics, or metabolomics, and do not consider environmental and sociological characteristics that influence genetic traits over time.
Innovation Solution
A pharmacological phenotype prediction system trained with machine learning techniques that analyzes panomic, sociological, and environmental data to predict drug responses, disease risks, and other pharmacological phenotypes by generating a statistical model that incorporates genomic, epigenomic, chromatin state, proteomic, and metabolomic data, along with sociological and environmental factors.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If current systems use only coding genome data to predict drug response, then the prediction system is simple, but the prediction accuracy is insufficient because noncoding genomic variants and other omics data are not utilized
Solution Approach 1:
The patent merges multiple data sources including coding and noncoding genomic variants, epigenomic alterations, chromatin state, and other omics data into a unified prediction system. This integration of diverse data types enables comprehensive analysis of genetic and environmental factors influencing drug response, thereby improving prediction accuracy while managing system complexity through coordinated processing.
Solution Approach 2:
The prediction system is designed to handle multiple types of biological data (genomic, epigenomic, transcriptomic, proteomic, metabolomic) and environmental factors through a single multi-functional platform. This universal approach allows the system to process diverse inputs using machine learning techniques to generate comprehensive pharmacological phenotype predictions.
2Adaptability or versatility
If the system incorporates multiple omics data and environmental factors, then prediction comprehensiveness improves, but data processing complexity increases
Solution Approach 1:
The patent employs machine learning algorithms as intermediary components that process and integrate multiple omics data types and environmental factors. These algorithms serve as mediators that transform complex, multi-dimensional input data into actionable pharmacological phenotype predictions, managing data processing complexity while maintaining comprehensive analysis capabilities.
Solution Approach 2:
The system dynamically adjusts processing parameters and data weighting based on the specific combination of omics data and environmental factors provided for each patient. This adaptive parameter adjustment allows the system to optimize data processing for different data types and combinations, managing complexity while maintaining comprehensive prediction capabilities.
3Adaptability or versatility
If the system uses traditional statistical methods, then the system is easy to implement, but it cannot adapt to changes in biological characteristics and pharmacological phenotypes over time
Solution Approach 1:
The patent implements dynamic machine learning models that continuously adapt to changing biological characteristics and pharmacological phenotypes over time. These dynamic systems update their parameters and predictions based on new data, enabling the system to respond to temporal changes in patient conditions, disease progression, and treatment responses while maintaining manageable complexity through iterative learning.
Solution Approach 2:
The system incorporates feedback mechanisms where prediction outcomes and new patient data are fed back into the machine learning models to continuously improve accuracy and adaptability. This feedback loop enables the system to learn from actual patient responses and update its predictions, achieving adaptability to changes while managing complexity through structured learning processes.
Data Source
AI summary
For patients who exhibit or may exhibit primary or comorbid disease, pharmacological phenotypes may be predicted through the collection of panomic data over a period of time. A machine learning engine may generate a statistical model based on training data from training patients to predict pharmacological phenotypes, including drug response and dosing, drug adverse events, disease and comorbid disease risk, drug-gene, drug-drug, and polypharmacy interactions. Then the model may be applied to data for new patients to predict their pharmacological phenotypes, and enable decision making in clinical and research contexts, including drug selection and dosage, changes in drug regimens, polypharmacy optimization, monitoring, etc., to benefit from additional predictive power, resulting in adverse event and substance abuse avoidance, improved drug response, better patient outcomes, lower treatment costs, public health benefits, and increases in the effectiveness of research in pharmacology and other biomedical fields.